|
|
| Dr. David J. Moliterno Discusses the TRA-PCI Trial |
Dr. David J. Moliterno discusses the thrombin receptor antagonist(TRA)-PCI Trial.
Sponsorship for interviews this year at TCT 2007 was provided by the Center for Health
Education (CHE) through unrestricted joint educational grants from Daiichi Sankyo Lilly,
Genentech, Pfizer, Sanofi-Aventis, Schering-Plough and Scios.
[ Download video ] |
|
No comments have been submitted
|